Interleukin-18 in Adult-onset Still's Disease: Treatment Target or Disease Activity Indicator?
スポンサーリンク
概要
著者
-
Iwamoto Masahiro
Division Of Rheumatology And Clinical Immunology Department Of Medicine Jichi Medical University
-
Minota Seiji
Division Of Rheumatology And Clinical Immunology Department Of Internal Medicine Jichi Medical Schoo
-
Nagashima Takao
Division Of Rheumatology And Clinical Immunology Department Of Medicine Jichi Medical School
-
Matsumoto Kazuko
Division Of Heart Failure Cardiovascular Medicine National Cerebral And Cardiovascular Center
関連論文
- Efficacy and safety of mizoribine for the treatment of Sjogren's syndrome : a multicenter open-label clinical trial
- Rapidly Progressed Secondary Amyloidosis in a Patient with Mixed Connective Tissue Disease
- Anti-HSP auto-antibodies enhance HSP-induced pro-inflammatory cytokine production in human monocytic cells via Toll-like receptors
- Rheumatoid Arthritis Complicated with Acute Interstitial Pneumonia Induced by Leflunomide as an Adverse Reaction
- Dermatomyositis and cutaneous necrosis: report of five cases
- Decrease in the levels of anti-cyclic citrullinated peptide antibody in Japanese patients with rheumatoid arthritis who responded to anti-tumor necrosis factor-α
- Semiquantitative assessment of the intestinal motility in chronic intestinal pseudo-obstruction in systemic sclerosis and mixed connective tissue disease by Sitzmarks capsule
- Successful Treatment of a Patient with Rheumatoid Arthritis and IgA-Kappa Multiple Myeloma with Tocilizumab
- Elevated muscle enzymes in a patient with severe hypocalcemia mimicking polymyositis
- Sjogren's Syndrome Associated with Chronic Hepatitis C, Severe Thrombocytopenia, Hypertrophic Cardiomyopathy, and Diabetes Mellitus
- Antiribosomal-P protein antibodies are associated with proliferative glomerulonephritis more strongly than with membranous glomerulonephritis in Japanese patients with systemic lupus erythematosus
- Radiological features and therapeutic responses of pulmonary nontuberculous mycobacterial disease in rheumatoid arthritis patients receiving biological agents : a retrospective multicenter study in Japan
- Comment on "Comparison of MMP-3 levels in rheumatoid arthritis after treatment with tocilizumab or infliximab for 12 weeks" by Yokoe et al
- Therapeutic response of patients with adult Still's disease to biologic agents : multicenter results in Japan
- Influence of antibodies against infliximab and etanercept on the treatment effectiveness of these agents in Japanese patients with rheumatoid arthritis
- ANCA in Atheroembolism; Just a Coincidence or Bearing Cause and Effect?
- Marked Colonic Wall Thickening in Lupus Enteritis
- Interleukin-18 in Adult-onset Still's Disease: Treatment Target or Disease Activity Indicator?
- Progressive Multicentric Reticulohistiocytosis
- Radiographic Features of Rhupus Arthropathy